Side Effects

How Long Do Semaglutide Side Effects Last? A Week-by-Week Breakdown

GLP-1 Companion · 8 min read

One of the most common questions from people starting semaglutide (Ozempic, Wegovy, or Rybelsus) is simple: how long does this last? Nausea, fatigue, and digestive discomfort are real — but for most patients they are temporary. Understanding the timeline helps you set realistic expectations and avoid stopping a medication before it has a chance to work.

Why Side Effects Happen — and Why They Fade

Semaglutide activates GLP-1 receptors throughout the body, including a dense cluster in the gut. This slows gastric emptying — the rate at which food moves from your stomach into the small intestine. The slower transit is what produces weight loss benefits, but it is also what causes nausea, bloating, and constipation early on. Over time your body adapts: gastric neurons recalibrate, and the same drug concentration produces far fewer symptoms. This adaptation is the reason side effects are front-loaded, not permanent.

Week-by-Week Timeline for Semaglutide Side Effects

Weeks 1–2: The Peak

The first week at any dose — including the lowest starting dose of 0.25 mg (Ozempic) or 0.25 mg (Wegovy) — is typically when side effects are most intense. Nausea affects 35–45% of patients and tends to be worst in the 4–8 hours after the weekly injection. Fatigue, mild headaches, and loose stools are also common. Most people find mornings easier and afternoons harder on injection days.

Weeks 3–4: Improvement Begins

By week three, the majority of patients report that nausea is noticeably better. Gastric adaptation is underway and the body has experienced two to three weekly doses. Constipation can actually become more pronounced at this stage as GI motility remains slowed but the initial adjustment nausea is resolving. Staying well hydrated and increasing fiber intake helps significantly.

Weeks 5–8: Resolution for Most Patients

Clinical trial data from the STEP 1 and STEP 2 trials show that GI side effects in most participants diminish substantially by weeks 6–8 at a stable dose. Patients who were experiencing daily nausea often find it has become occasional or absent entirely by the end of this window. Fatigue typically resolves earlier, often by weeks 3–4, as the body adjusts to reduced calorie intake.

After a Dose Increase: The Cycle Resets

Wegovy and Ozempic are both titrated upward over months. Each time the dose increases — for example moving from 0.5 mg to 1.0 mg, or from 1.0 mg to 1.7 mg on Wegovy — the side effect cycle can temporarily reset. Expect 1–2 weeks of increased GI symptoms after each new dose level, followed by the same 4–8 week adaptation period. This is normal and expected, not a sign that the medication is no longer tolerable.

Specific Side Effect Timelines

• Nausea: Peaks in weeks 1–2 at each dose, typically resolves by weeks 6–8. Around 5–10% of patients have persistent mild nausea at maintenance doses.
• Constipation: Can peak later than nausea (weeks 3–6) and may require active management with fiber and hydration throughout treatment.
• Diarrhea / loose stools: Most common in the first 4 weeks, usually resolves on its own by week 6.
• Fatigue: Typically improves by weeks 3–4 as the body adapts to lower caloric intake.
• Headaches: Usually linked to dehydration and resolve within weeks 1–3 with adequate fluid intake.
• Injection-site reactions: Minor redness or itching, usually within 24–48 hours of injection and self-resolving.
• Acid reflux / heartburn: Can persist longer, especially in those with pre-existing reflux. May require dietary modifications throughout treatment.

Do Side Effects Last Forever on High Doses?

No. Even on the highest Wegovy maintenance dose (2.4 mg weekly), most patients in the STEP trials reached a stable side-effect profile by months 3–4. A minority of patients — approximately 5–7% — discontinue semaglutide due to intolerable GI side effects in clinical trials. For the vast majority, symptoms are manageable and transient.

What Makes Side Effects Last Longer Than Average

Several factors can extend how long side effects persist. Eating large meals, high-fat foods, or carbonated drinks intensifies and prolongs nausea. Dehydration worsens headaches and constipation. Moving up the dose faster than recommended (skipping titration steps) is one of the most common reasons patients experience severe or unusually prolonged side effects. Finally, underlying gastroparesis or pre-existing acid reflux can make GI symptoms more severe and longer-lasting.

Strategies That Shorten the Side Effect Window

1. Stick strictly to the recommended titration schedule — never increase the dose ahead of schedule.
2. Inject on the same day each week, at the same time of day, to maintain a predictable peak-and-trough drug level.
3. Eat smaller meals: no more than what fits in two cupped hands. The medicated stomach cannot process large volumes efficiently.
4. Avoid fatty and fried foods during the first 4–8 weeks at any new dose.
5. Hydrate consistently — at least 64 ounces of water daily. Dehydration is one of the top drivers of prolonged headaches and constipation.
6. Use ginger (tea, capsules, or chews) proactively to reduce nausea before and after injection day.
7. Ask your provider about anti-nausea medication (such as ondansetron or promethazine) for the first few weeks if side effects are severe.

When to Call Your Doctor

Most semaglutide side effects are self-resolving. Contact your prescribing provider if you experience vomiting that prevents keeping fluids down for more than 24 hours, severe or persistent upper abdominal pain (which can indicate pancreatitis), significant weight loss that seems too rapid, or any signs of severe dehydration such as dark urine, dizziness when standing, or confusion.

The Bottom Line

For most people, semaglutide side effects follow a predictable arc: they peak in the first 1–2 weeks at each dose level and significantly resolve by weeks 6–8. Every dose escalation resets this cycle briefly. Understanding this timeline — and knowing what you can do to shorten it — makes it much easier to stay on treatment long enough to see meaningful results.

Sources

• Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM, 2021.
• Davies M et al. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet, 2021.
• FDA Prescribing Information — Wegovy (semaglutide) injection, 2021.